DrugPatentWatch Database Preview
DULOXETINE HYDROCHLORIDE Drug Profile
When do Duloxetine Hydrochloride patents expire, and when can generic versions of Duloxetine Hydrochloride launch?
Duloxetine Hydrochloride is a drug marketed by Actavis Elizabeth, Ajanta Pharma Ltd, Alembic Pharms Ltd, Alkem Labs Ltd, Anchen Pharms, Apotex Inc, Aurobindo Pharma Ltd, Breckenridge Pharm, Cspc Ouyi Pharm Co, Hetero Labs Ltd Iii, Inventia Hlthcare, Lupin Ltd, Macleods Pharms Ltd, Marksans Pharma, Prinston Inc, Sun Pharma Global, Teva Pharms Usa, Torrent Pharms Ltd, Zydus Hlthcare, and Zydus Pharms Usa Inc. and is included in twenty NDAs.
The generic ingredient in DULOXETINE HYDROCHLORIDE is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the duloxetine hydrochloride profile page.
Summary for DULOXETINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 20 |
| Suppliers / Packagers: | 48 |
| Bulk Api Vendors: | 81 |
| Clinical Trials: | 280 |
| Patent Applications: | 24 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DULOXETINE HYDROCHLORIDE at DailyMed |
Pharmacology for DULOXETINE HYDROCHLORIDE
| Drug Class | Serotonin and Norepinephrine Reuptake Inhibitor |
| Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for DULOXETINE HYDROCHLORIDE
Synonyms for DULOXETINE HYDROCHLORIDE
| (+)-(S)-N-methyl-.gamma.-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride |
| (+)-(S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propanamine hydrochloride |
| (+)-(S)-N-METHYL-G-(1-NAPHTHYLOXY)-2-THIOPHENEPROPYLAMINE, HYDROCHLORIDE |
| (+)-(S)-N-Methyl-gamma-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride |
| (+)-N-METHYL-3-(1-NAPHTHALENYLOXY)-3-(2-THIENYL)PROPANAMINE HYDROCHLORIDE |
| (+)-N-methyl-gamma-(1-napthlenloxy)-2-thiophenepropan-amine hydrochloride |
| (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride |
| (3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(2-thienyl)propan-1-amine hydrochloride |
| (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine hydrochloride |
| (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride |
| (GAMMAS)-N-METHYL-GAMMA-(1-NAPHTHALENYLOXY)-2-THIOPHENEPROPANAMINE HYDROCHLORIDE |
| (S)-(+)-DULOXETINE HYDROCHLORIDE |
| (S)-(+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine hydrochloride |
| (S)-(+)-N-METHYL-3-(1-NAPHTHALENYLOXY)-3-(2-THIENYL)PROPANAMINE HYDROCHLORIDE |
| (S)-(+)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine Hydrochloride |
| (S)-Duloxetine (hydrochloride) |
| (S)-Duloxetine HCl |
| (S)-duloxetine hydrochloride |
| (S)-Duloxetine hydrochloride, >=98% (HPLC) |
| (S)-METHYL-[3-(NAPHTHALEN-1-YLOXY)-3-THIOPHEN-2-YL-PROPYL]-AMINE HYDROCHLORIDE |
| (S)-N-METHYL-3-(NAPHTHALEN-1-YLOXY)-3-(THIOPHEN-2-YL)PROPAN-1-AMINE HCL |
| (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride |
| (S)-N-METHYL-GAMMA-(1-NAPHTHALENYLOXY)-2-THIOPHENEPROPANAMINE HYDROCHLORIDE |
| 136434-34-9 |
| 2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, hydrochloride, (gammaS)- |
| 2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, hydrochloride, (S)- |
| 434D349 |
| 9044SC542W |
| AB0008489 |
| AB2000488 |
| AB23771 |
| AC-924 |
| AC1L1U0N |
| AC1Q3DMM |
| AK-72899 |
| AKOS016340453 |
| AN-253 |
| ANW-52464 |
| API0002507 |
| Ariclaim |
| AX8017673 |
| BFFSMCNJSOPUAY-LMOVPXPDSA-N |
| BR-72899 |
| C18H19NOS.HCl |
| C18H20ClNOS |
| CAS-136434-34-9 |
| CCG-101106 |
| CD0196 |
| CHEBI:31526 |
| CHEMBL1200328 |
| CPD000469136 |
| CS-1993 |
| Cymbalta |
| Cymbalta (TN) |
| Cymbalta|||Dulane 20|||LY 248686 HCl |
| D01179 |
| D4223 |
| DSSTox_CID_26443 |
| DSSTox_GSID_46443 |
| DSSTox_RID_81618 |
| DTXSID9046443 |
| Dulane 20 |
| Duloxetine (hydrochloride) |
| Duloxetine for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Duloxetine HCl |
| Duloxetine HCl (Cymbalta) |
| Duloxetine hydrochloride (JAN/USAN) |
| Duloxetine hydrochloride [USAN] |
| Duloxetine Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Duloxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Duloxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
| Duloxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| duloxetine hydrochlorise |
| EBD2816 |
| EBD29778 |
| FT-0648818 |
| HE222122 |
| HY-B0161A |
| J10476 |
| KB-50492 |
| KS-1168 |
| LS-172959 |
| LY 248686 HCl |
| LY-248686 |
| LY-248686 HYDROCHLORIDE |
| LY-264453 |
| LY248686 HCl |
| methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine hydrochloride |
| MFCD06407958 |
| MLS001401452 |
| MLS006010054 |
| MolPort-003-666-661 |
| N-Methyl-gama- -2-thiophenepropanamine |
| NC00356 |
| NCGC00164559-01 |
| NCGC00164559-03 |
| NSC-744012 |
| NSC-759112 |
| NSC744012 |
| NSC759112 |
| Pharmakon1600-01505387 |
| Q-102508 |
| S-4928 |
| s2084 |
| SAM001246523 |
| SC-00924 |
| SMR000469136 |
| ST24026653 |
| TC-141209 |
| Tox21_112188 |
| Tox21_112188_1 |
| UNII-9044SC542W |
| Xeristar |
